October 2017 - Page 5 of 20

SunPower Corporation’s Rating Lowered by Zacks Investment Research

In a report on Tuesday, Zacks Investment Research lowered their SunPower Corporation (NASDAQ:$SPWR) stock rating from ‘Buy’ to ‘Hold’. “SunPower is gradually shifting its revenue base from solar panel sales to the development of solar ... [Read]

Patriot One Technologies, Inc. Announces Increase to Previous Bought Deal Financing

Oct 23 Jen Jiang

Patriot One Technologies Inc. (OTC:$PTOTF) officially announced today that it has entered into an amending agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the “Underwriters”) (TSX:$CF) to increase the size of its ... [Read]

Market Movers: PyroGenesis Canada Inc Shares went up 33.3%

Oct 23 Jackson Chen

On Monday, PyroGenesis Canada Inc (TSX-V:$PYR) announced that it has successfully completed the ramp-up phase of its first plasma atomization system. Its share price went up to $0.68 from $0.51, a 33.3% increase. Atico Mining ... [Read]

A Look At Dolcat Ventures Inc.’s Recent Performance

Oct 23 Jen Jiang

Dolat Ventures, Inc. (OTC:$DOLV) shares are seeing a positive momentum over the past week as the stock has clocked in with gains of -11.54%. In the bigger picture, shares of the company have moved 7.81% ... [Read]

Amfil Technologies Moving On Volatility: A Look At the Numbers

Amfil Technologies Moving On Volatility: A Look At the Numbers (Sponsored)

Apr 8 Jen Jiang

The OTC listed Amfil Technologies (OTC:$AMFE) recently saw a bid of 0.1965 on 2663903 volume. Shares of the company is moving on volatility today 4.8%, or 0.009 from the open. Amfil sees a 14-day ATR ... [Read]

Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’

Oct 20 Dylan Bernhardt

A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]

Is Impax Laboratories a Buy At $16?

Oct 20 Dylan Bernhardt

Impax Laboratories (NASDAQ:$IPXL) currently has a going rate of $20.75 per share. This could be a shaky proposition for some investors. However, there may be another way to get in on the drug manufacturer’s stock. ... [Read]

Trevali Mining Corp Receives ‘Outperform’ Rating From Scotiabank

Oct 20 Dylan Bernhardt

In a research report released Tuesday, Trevali Mining Corp (TSXV:$TV) received “Outperform” rating from Scotiabank. They also set a price target of $2.00. Trevali Mining Corp is a Canadian mining company that is currently engaged ... [Read]

52-Week High Broken By OraSure

Oct 20 Dylan Bernhardt

During trading yesterday, stocks of OraSure Technologies Inc. (NASDAQ:$OSUR) set a new 52-week high when it hit prices of $23.01. Shares that day opened at $22.90 and closed at $22.78, representing a change of 0.04%. The ... [Read]

Kulicke And Soffa Industries, Inc: What Price Targets are Analysts Setting?

Oct 20 Dylan Bernhardt

On October 4, Kulicke and Soffa Industries, Inc. (NASDAQ:$KLIC) saw their stock price open at $21.99 during day trading. The stock also had a daily high of $22.08 and a daily low of $21.80. At the ... [Read]